| NP0351483 | Cannabizetol | |  | C43H64O4
644.9810 Da 644.48046 Da | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 101 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 400 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, CD3OD, experimental) |
|
| NP0351482 | Cannabitwinol | |  | C43H60O4
640.9490 Da 640.44916 Da | |
| NP0351481 | Luxocinnamycin C_re | |  | C26H31N3O7
497.5480 Da 497.21620 Da | | [1H, 1H] NMR Spectrum (2D, 800 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 800 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 201 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, C2D6OS, experimental) | | [1H, 15N] NMR Spectrum (2D, 800 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, C2D6OS, experimental) | | [1H, 15N] NMR Spectrum (2D, 800 MHz, C2D6OS, experimental) |
|
| NP0351480 | Gwanacinnamycin | |  | C64H88N14O13
1261.4930 Da 1260.66553 Da | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 800 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 201 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, C2D6OS, experimental) | | [1H, 15N] NMR Spectrum (2D, 800 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, C2D6OS, experimental) |
|
| NP0351479 | Oxy-skyllamycin B | |  | C74H92N12O21
1485.6130 Da 1484.65000 Da | | [1H, 13C] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 800 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 201 MHz, CD3OD, experimental) |
|
| NP0351478 | Oxy-skyllamycin A | |  | C75H94N12O21
1499.6400 Da 1498.66565 Da | | [1H, 13C] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 201 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 800 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) |
|
| NP0351477 | Luxocinnamycin D | |  | C13H15NO4
249.2660 Da 249.10011 Da | | [1H, 13C] NMR Spectrum (2D, 800 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 800 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 201 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, C2D6OS, experimental) | | [1H, 15N] NMR Spectrum (2D, 800 MHz, C2D6OS, experimental) |
|
| NP0351476 | Luxocinnamycin B | |  | C40H44N6O12
800.8220 Da 800.30172 Da | | [1H, 13C] NMR Spectrum (2D, 800 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 800 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 201 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, C2D6OS, experimental) | | [1H, 15N] NMR Spectrum (2D, 800 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, C2D6OS, experimental) | | [1H, 15N] NMR Spectrum (2D, 800 MHz, C2D6OS, experimental) | | [1H, 15N] NMR Spectrum (2D, 800 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, C2D6OS, experimental) |
|
| NP0351475 | Luxocinnamycin A | |  | C51H56N8O14
1005.0510 Da 1004.39160 Da | | 1H NMR Spectrum (1D, 800 MHz, C3H7NO, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, C3H7NO, experimental) | | [1H, 15N] NMR Spectrum (2D, 800 MHz, C3H7NO, experimental) | | [1H, 15N] NMR Spectrum (2D, 800 MHz, C3H7NO, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, C3H7NO, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, C3H7NO, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, C3H7NO, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, C3H7NO, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, C3H7NO, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, C3H7NO, experimental) | | 13C NMR Spectrum (1D, 201 MHz, C3H7NO, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, C3H7NO, experimental) |
|
| NP0351474 | Hydrolysis artifact of Purpurinidin | |  | C21H13O7
377.3270 Da 377.06558 Da | | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
| NP0351473 | cyclo(L-Pro-L-Phe) | |  | C14H16N2O2
244.2940 Da 244.12118 Da | |
| NP0351470 | 2-acetamido-3-hydroxybenzoic acid | |  | C9H9NO4
195.1740 Da 195.05316 Da | |
| NP0351469 | Campestridin G | |  | C45H78O22
971.0970 Da 970.49847 Da | | 13C NMR Spectrum (1D, 201 MHz, C5D5N, experimental) | | 1H NMR Spectrum (1D, 800 MHz, C5D5N, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, C5D5N, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, C5D5N, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, C5D5N, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, C5D5N, experimental) |
|
| NP0351468 | Campestridin F | |  | C43H74O21
927.0440 Da 926.47226 Da | | 13C NMR Spectrum (1D, 226 MHz, C5D5N, experimental) | | 1H NMR Spectrum (1D, 900 MHz, C5D5N, experimental) | | [1H, 1H] NMR Spectrum (2D, 900 MHz, C5D5N, experimental) | | [1H, 13C] NMR Spectrum (2D, 900 MHz, C5D5N, experimental) | | [1H, 13C] NMR Spectrum (2D, 900 MHz, C5D5N, experimental) | | [1H, 1H] NMR Spectrum (2D, 900 MHz, C5D5N, experimental) |
|
| NP0351467 | Campestridin E | |  | C43H74O21
927.0440 Da 926.47226 Da | | 13C NMR Spectrum (1D, 201 MHz, C5D5N, experimental) | | 1H NMR Spectrum (1D, 800 MHz, C5D5N, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, C5D5N, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, C5D5N, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, C5D5N, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, C5D5N, experimental) |
|
| NP0351466 | Campestridin D | |  | C42H72O20
897.0180 Da 896.46169 Da | | 13C NMR Spectrum (1D, 226 MHz, C5D5N, experimental) | | 1H NMR Spectrum (1D, 900 MHz, C5D5N, experimental) | | [1H, 13C] NMR Spectrum (2D, 900 MHz, C5D5N, experimental) | | [1H, 13C] NMR Spectrum (2D, 900 MHz, C5D5N, experimental) | | [1H, 1H] NMR Spectrum (2D, 900 MHz, C5D5N, experimental) | | [1H, 1H] NMR Spectrum (2D, 900 MHz, C5D5N, experimental) |
|
| NP0351465 | Campestridin C | |  | C44H76O20
925.0720 Da 924.49299 Da | | 13C NMR Spectrum (1D, 226 MHz, C5D5N, experimental) | | 1H NMR Spectrum (1D, 900 MHz, C5D5N, experimental) | | [1H, 1H] NMR Spectrum (2D, 900 MHz, C5D5N, experimental) | | [1H, 13C] NMR Spectrum (2D, 900 MHz, C5D5N, experimental) | | [1H, 13C] NMR Spectrum (2D, 900 MHz, C5D5N, experimental) | | [1H, 1H] NMR Spectrum (2D, 900 MHz, C5D5N, experimental) | | [1H, 1H] NMR Spectrum (2D, 900 MHz, C5D5N, experimental) |
|
| NP0351464 | Campestridin B | |  | C44H74O21
939.0550 Da 938.47226 Da | | 13C NMR Spectrum (1D, 101 MHz, C5D5N, experimental) | | 1H NMR Spectrum (1D, 400 MHz, C5D5N, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, C5D5N, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, C5D5N, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, C5D5N, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, C5D5N, experimental) |
|
| NP0351463 | Campestridin A | |  | C42H70O21
911.0010 Da 910.44096 Da | | 1H NMR Spectrum (1D, 900 MHz, C5D5N, experimental) | | [1H, 1H] NMR Spectrum (2D, 900 MHz, C5D5N, experimental) | | [1H, 13C] NMR Spectrum (2D, 900 MHz, C5D5N, experimental) | | [1H, 13C] NMR Spectrum (2D, 900 MHz, C5D5N, experimental) | | [1H, 1H] NMR Spectrum (2D, 900 MHz, C5D5N, experimental) | | 13C NMR Spectrum (1D, 226 MHz, C5D5N, experimental) |
|
| NP0351462 | Cyclocircadin H | |  | C22H32O4
360.4940 Da 360.23006 Da | | 13C NMR Spectrum (1D, 600.1723, CDCl3, simulated) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
| NP0351461 | Cyclocircadin G | |  | C20H32O2
304.4740 Da 304.24023 Da | | 13C NMR Spectrum (1D, 600.1723, CDCl3, simulated) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
| NP0351460 | Cyclocircadin F | |  | C20H30O2
302.4580 Da 302.22458 Da | | 13C NMR Spectrum (1D, 600.1723, CDCl3, simulated) | | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
| NP0351459 | Cyclocircadin E | |  | C20H30O4
334.4560 Da 334.21441 Da | | 13C NMR Spectrum (1D, 600.1723, CD3OD, simulated) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) |
|
| NP0351458 | Cyclocircadin D | |  | C20H30O4
334.4560 Da 334.21441 Da | | 13C NMR Spectrum (1D, 600.1723, CD3OD, simulated) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
| NP0351457 | Cyclocircadin C | |  | C20H28O4
332.4400 Da 332.19876 Da | | 13C NMR Spectrum (1D, 600.1723, CD3OD, simulated) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|